SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kyprianou N. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol 2003; 169: 15205
  • 2
    Mudiyala R, Ahmed A. Effect of terazosin on clinical benign prostatic hyperplasia in older adults. J Am Geriatr Soc 2003; 51: 4246
  • 3
    Souverein PC, Herings RM, Man in ’tVeld AJ, De La Rosette JJ, Farmer RD, Leufkens HG. Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia. Eur Urol 2002; 42: 25461
  • 4
    Pool JL, Kirby RS. Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. Int Urol Nephrol 2001; 33: 40712
  • 5
    Dunn CJ, Matheson A, Faulds DM. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging 2002; 19: 13561
  • 6
    Wilt TJ, MacDonald R, Rutks I. Tamsulosin for benign prostatic hyperplasia. Cochrane Database Syst Rev 2003; 1: CD002081
  • 7
    Kumar A, Mandhani A, Gogoi S, Srivastava A. Management of functional bladder neck obstruction in women: use of alpha-blockers and pediatric resectoscope for bladder neck incision. J Urol 1999; 162: 20615
  • 8
    Jung SY, Fraser MO, Ozawa H et al. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol 1999; 162: 20412
  • 9
    Wein AJ. Voiding function and dysfunction, bladder physiology and pharmacology, and female urology. J Urol 2004; 171: 251832
  • 10
    Shafik A. On the physioanatomy of micturition and urinary continence – new concepts. Adv Exp Med Biol 2003; 539: 381414
  • 11
    Gallagher DJ, Montgomerie JZ, North JD. Acute infections of the urinary tract and the urethral syndrome in general practice. Br Med J 1965; 5435: 6226
  • 12
    Barbalias GA, Meares EM Jr. Female urethral syndrome: clinical and urodynamic perspectives. Urology 1984; 23: 20812
  • 13
    Bergman A, Karram M, Bhatia NN. Urethral syndrome. A comparison of different treatment modalities. J Reprod Med 1989; 34: 15760
  • 14
    Raz S, Smith RB. External sphincter spasticity syndrome in female patients. J Urol 1976; 115: 4436
  • 15
    Durant PA, Lucas PC, Yaksh TL. Micturition in the unanesthetized rat: spinal vs. peripheral pharmacology of the adrenergic system. J Pharmacol Exp Ther 1988; 245: 42635
  • 16
    Yoon DH, Lee JG. The role of peripheral and spinal a1-adrenoceptor in bladder overactivity induced by partial bladder outlet obstruction in rat. Korean J Urol 2000; 41: 95967
  • 17
    Kim YD, Lee JG. In vitro responses of alpha-adrenergic antagonist of rat detrusor muscle after partial bladder outlet obstruction. Korean J Urol 1999; 40: 45863
  • 18
    Jeong MS, Lee JG. The role of spinal and peripheral á1 adrenoceptors in micturition reflex in rats. Korean J Urol 1999; 40: 117480
  • 19
    Takahashi H, Takeda M, Shimura H et al. Alpha-1 adrenoceptor subtypes in the human female urethra – RT-PCR, in situ hybridization and quantitative autoradiography. Neurourol Urodyn 1996; 15: 34215
  • 20
    Auguet M, Delaflotte S, Chabrier PE. Different alpha1-adrenoceptor subtypes mediate contraction in rabbit aorta and urethra. Eur J Pharmacol 1995; 287: 15361
  • 21
    Chess-Williams R, Aston N, Couldwell C. Alpha 1A-adrenoceptor subtype mediates contraction of the rat urethra. J Auton Pharmacol 1994; 14: 37581
  • 22
    Alberts P, Bergstrom PA, Fredrickson MG. Characterisation of the functional alpha-adrenoceptor subtype in the isolated female pig urethra. Eur J Pharmacol 1999; 371: 318
  • 23
    Ahmed H, Moriyama N, Fukasawa R et al. Contractile properties of urethral smooth muscles of young and aged female dogs: morphological and pharmacological aspects. Int J Urol 2000; 7: 298306